White zinc oxide powder with ≥99% ZnO assay for supplement formulations

Zinc Oxide Powder

Zinc Oxide Powder is a white inorganic zinc ingredient typically supplied at ≥99% ZnO and 200 mesh for capsules, tablets, mineral premixes, powder blends, sachets, gummies, and chewables. Sourced through qualified manufacturing partners in China, it is supported by specification review, representative samples, batch documentation, traceability controls, and international bulk supply for supplement brands, contract manufacturers, importers, distributors, formulators, and QA/QC teams.

Top Key Specs

ItemTypical Specification / Supply Information
Product NameZinc Oxide Powder
Chemical NameZinc oxide
CAS Number1314-13-2
Molecular FormulaZnO
ZnO AssayTypically ≥99%, confirmed by batch COA
Elemental ZincApproximately 79.5% at a 99% ZnO assay
AppearanceWhite to off-white fine powder
Particle Size200 mesh typical; alternatives subject to confirmation
SolubilityPractically insoluble in water
Loss on DryingTypically ≤0.5%, or as agreed
Heavy Metal ControlPb, As, Cd, and Hg reviewed against agreed limits
Main ApplicationsCapsules, tablets, mineral premixes, powder blends, sachets, gummies, and chewables
Country of OriginChina
Standard Packaging25 kg kraft paper bag, carton, fiber drum, or agreed packaging
Shelf Life / StorageTypically 36 months; store sealed in a cool, dry, well-ventilated area
DocumentsCOA, TDS, SDS, specification sheet, origin information, and available declarations

Elemental Zinc (%) = ZnO Assay (%) × 0.803

At a 99% ZnO assay, the calculated elemental zinc content is approximately 79.5%. Commercial input should be calculated from the actual batch assay. As a dense, water-insoluble mineral, zinc oxide requires application testing for blending, compression, sedimentation, color, and sensory performance.

Typical COA Limits

Typical Batch Controls

ParameterTypical Limit / Review Basis
AppearanceWhite to off-white fine powder
IdentificationConforms
Zinc Oxide AssayTypically ≥99.0%, or as agreed
Loss on DryingTypically ≤0.5%, or as agreed
Particle Size200 mesh typical, or agreed particle-size target
LeadTypically ≤2 ppm, or agreed market limit
ArsenicTypically ≤1 ppm, or agreed limit
CadmiumTypically ≤1 ppm, or agreed limit
MercuryTypically ≤0.1 ppm, or agreed limit
Total Plate CountTested when required
Yeast and MoldTested when required
PathogensNegative when included in the test scope

Optional Project Controls

ParameterAvailable Review
Detailed Particle-Size DistributionSieve residue, D90, or another agreed parameter
Bulk DensityReviewed for blending, dosing, and filling trials
Whiteness / ColorVisual or instrumental review when required
Customer-Specified TestingCoordinated after methods, limits, and reporting needs are confirmed

Zinc oxide should be approved against a written specification defining identity, assay, particle size, moisture, contaminant limits, applicable microbiology, packaging, storage, and required documents. Representative files may support initial supplier qualification, while commercial release should use the COA issued for the supplied production lot.

Particle size and density may influence blending, transfer, filling, compression, sedimentation, and sensory performance even when the chemical assay meets its limit. Repeat orders should therefore be reviewed against the agreed specification and previous approved lots. Essencefield’s Raw Material Quality process covers supplier qualification, incoming review, COA verification, and lot traceability. Available methods, certification scope, and independent verification can be discussed through Testing & Certifications.

Features & Benefits

  • High ZnO Assay: A typical ≥99% specification provides a concentrated inorganic zinc input for compact formulations.
  • Batch-Based Calculation: Elemental zinc input can be calculated from the assay reported on the production-lot COA.
  • Consistent Powder Specification: A typical 200-mesh specification supports blending, capsule filling, premix preparation, and tableting trials.
  • Risk-Based Quality Control: Assay, moisture, particle size, heavy metals, and applicable microbiology are reviewed against agreed limits.
  • Documented Bulk Supply: Samples, quality documents, traceability records, 25 kg packaging, and repeat-order support are available for B2B projects.

Ingredient selection should reflect the intended dosage format. Compare Zinc Gluconate Powder when a water-soluble zinc salt is preferred, or Zinc Glycinate Powder when a glycinate-based zinc format is required.

Applications & Formulation Ideas

Primary Applications

ApplicationFormulation Focus
Hard CapsulesPowder flow, fill weight, segregation, and content uniformity
TabletsCompression, hardness, friability, and disintegration
Mineral PremixesCarrier selection, low-dose distribution, and segregation control
Powder Blends and SachetsFlow, sedimentation, reconstitution, and re-dispersion
Gummies and ChewablesColor, chalkiness, flavor, and mineral distribution
Private Label SupplementsSample review, pilot production, and batch documentation

Elemental Zinc Calculation Reference

The calculations below are based on approximately 79.5% elemental zinc at a 99% ZnO assay.

Target Elemental ZincApproximate Zinc Oxide Input
5 mg6.3 mg
10 mg12.6 mg
15 mg18.9 mg
20 mg25.2 mg

These values are formulation references only. Use the actual batch assay for commercial formulation and confirm the finished-product requirements of the destination market.

Formulation Guidance

  1. Calculate the required input from the batch ZnO assay and target elemental zinc level.
  2. Use a staged carrier preblend and match particle size and density when direct inclusion is too low for reliable distribution.
  3. Segregation risk: Dense zinc oxide may separate from proteins, fibers, botanicals, vitamins, or granular excipients. Verify uniformity at multiple sampling locations.
  4. Sedimentation risk: Treat zinc oxide as a suspended mineral solid rather than a soluble zinc source. Evaluate wetting, standing time, sediment height, and re-dispersion.
  5. Sensory risk: Gummies, chewables, and reconstituted powders may show opacity, chalkiness, or mineral mouthfeel. Screen the carrier, particle size, flavor, and acid system.
  6. Tablet process risk: Fine mineral powder may affect flow, tooling adhesion, compression force, hardness, friability, and disintegration.
  7. Process tip: Introduce zinc oxide through a controlled preblend and avoid excessive mixing that increases dust or agglomeration.
  8. QA release tip: Confirm raw-material identity, batch assay, weighing records, blend uniformity, finished-product zinc recovery, and unit-weight consistency. Repeat pilot testing after material or process changes.

Commercial scale-up should confirm that mineral distribution remains consistent from weighing through final packing. Density differences, transfer conditions, blender loading, and filling speed can cause a laboratory blend to behave differently in production. Capsule trials should assess flow and fill-weight variation, while tablet trials should review compression and disintegration. Gummy and chewable trials should evaluate color, texture, flavor, and zinc recovery after processing and storage. Powder formats should be tested under their intended preparation conditions.

Dosage-format development can be reviewed through Custom Formulation, while process verification and scale transition can be supported through Pilot Run & Scale-Up.

Packaging, Storage & Logistics

ItemSupply Information
Sample AvailabilityEvaluation packs for R&D, QA review, supplier qualification, and pilot trials
Inner PackagingFood-grade PE liner or moisture-protective inner bag
Standard Packaging25 kg kraft paper bag, carton, fiber drum, or agreed packaging
Label InformationProduct name, batch number, net weight, date, shelf life, storage condition, and origin
Shelf LifeTypically 36 months in unopened original packaging
StorageStore sealed in a cool, dry, well-ventilated area
Shipping OptionsCourier samples, air freight, sea freight, and consolidated export shipment
Export DocumentsCommercial invoice, packing list, COA, SDS, and origin information

Reseal opened packaging and protect the powder from moisture, contamination, and acidic materials. Confirm shipping marks, palletization, packaging configuration, and destination documents before dispatch.

MOQ, Lead Time, Documents & Inquiry

ItemB2B Supply Support
Standard MOQTypically 25–100 kg
Sample SupportAvailable for supplier approval, laboratory review, and formulation trials
Lead TimeCommonly 7–15 days for an available specification and routine documents
Custom RequirementsParticle size, contaminant limits, microbiology, testing, and packaging subject to review
DocumentsCOA, TDS, SDS, specification sheet, origin information, and available declarations
Buyer InformationTarget assay, particle size, application, quantity, destination, packaging, documents, and timeline

Request Ingredient Specs & Quote

Share your target specification, application, quantity and document needs. We will help confirm suitable options, COA/TDS/SDS support and bulk supply details.

Related Ingredients for Formulation

Explore related ingredients for formula comparison, complementary applications and alternative sourcing options across food, beverage, supplement and wellness projects.